Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06316973
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-03-05
Brief Title:
A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants
Sponsor:
Clear Scientific Inc
Organization:
Clear Scientific Inc
Study Overview
Official Title:
A Phase 1a Randomized Double-Blind Placebo-Controlled Single Center Study to Evaluate the Safety Tolerability and Pharmacokinetics of CS-1103 Following Single Ascending Intravenous Dose Administration in Healthy Participants
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this Phase 1a study is to evaluate safety tolerability and pharmacokinetics PK of single ascending doses of CS-1103 administered by intravenous IV infusion in healthy participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U01DA053054 | NIH | None | httpsreporternihgovquickSearchU01DA053054 |